Table 6.
Estimate outcome of ANCOVA analyses
Intercept |
Pre-treatment |
Condition |
|||||||
---|---|---|---|---|---|---|---|---|---|
b | SE | 95% CI | b | SE | 95% CI | b | SE | 95% CI | |
AOPFS | 2.48** | 0.66 | 1.14, 3.81 | 0.58** | 0.10 | 0.38, 0.77 | −0.19 | 0.20 | −0.59, 0.22 |
FSFI desire and satisfaction | 2.99** | 0.91 | 1.13, 4.85 | 0.59** | 0.17 | 0.24, 0.93 | −0.30 | 0.84 | −2.01, 1.40 |
Change in sexual desire | 1.86** | 0.56 | 0.73, 2.99 | 0.45 | 0.23 | −0.01, 0.91 | −0.27 | 0.54 | −1.37, 0.83 |
Guilt | 0.65 | 0.33 | 0.00, 1.33 | 0.29** | 0.10 | 0.08, 0.50 | −0.25 | 0.29 | −0.84, 0.35 |
Shame | 0.69 | 0.44 | −0.20, 1.57 | 0.36** | 0.13 | 0.10, 0.63 | −0.43 | 0.36 | −1.15, 0.29 |
The pre-treatment assessment of the measure was the covariate in the respective analyses. Reference category is TAU condition. Effects of AOPFS are based on transformed data. AOPFS = Amsterdam Overactive Pelvic Floor Scale for Women; FSFI = Female Sexual Functioning Index. *p < .05 **p < .01.